Literature DB >> 2211874

Influence of plasma glucose concentration on lumped constant of the deoxyglucose method: effects of hyperglycemia in the rat.

F Schuier1, F Orzi, S Suda, G Lucignani, C Kennedy, L Sokoloff.   

Abstract

The lumped constant of the deoxyglucose method was determined by the steady-state, model-independent method in the brain of normal conscious rats with arterial plasma glucose concentrations varying from normoglycemia (i.e., 8 mM) to hyperglycemia (i.e., 31 mM). The lumped constant for brain was found to decrease very gradually with increasing arterial plasma glucose concentration from a value of approximately 0.45 in the midnormoglycemic range (i.e., 7-8 mM) to approximately 0.38 at 28-31 mM. 3-O-[14C]Methylglucose was used to assess the distribution of glucose within the brain structures in hyperglycemia; the results indicated that the glucose concentration, and therefore also the values for the lumped constant, remain relatively uniform in hyperglycemia with arterial plasma glucose concentrations as high as 34 mM. The values for the lumped constant for rat brain determined in the present studies were combined with those previously determined in this laboratory for hypoglycemia and normoglycemia by the same method to provide a single source for the values for the lumped constant to be used over the full range of arterial plasma glucose concentrations. In several rats the lumped constant for cephalic extracerebral tissues was also evaluated in parallel with those for the brain. The lumped constant for the cephalic extracerebral tissues was found to be about twice that for brain and to be unaffected by changes in arterial plasma glucose levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2211874     DOI: 10.1038/jcbfm.1990.134

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  21 in total

1.  Glucose administration after traumatic brain injury improves cerebral metabolism and reduces secondary neuronal injury.

Authors:  Nobuhiro Moro; Sima Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2013-08-29       Impact factor: 3.252

2.  Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice.

Authors:  Koon-Pong Wong; Wei Sha; Xiaoli Zhang; Sung-Cheng Huang
Journal:  J Nucl Med       Date:  2011-04-15       Impact factor: 10.057

3.  Effect of hyperglycemia on brain and liver 18F-FDG standardized uptake value (FDG SUV) measured by quantitative positron emission tomography (PET) imaging.

Authors:  Benjamin L Viglianti; Ka Kit Wong; Stephanie M Wimer; Aishwarya Parameswaran; Bin Nan; Christy Ky; Danyelle M Townsend; Domenico Rubello; Kirk A Frey; Milton D Gross
Journal:  Biomed Pharmacother       Date:  2017-02-07       Impact factor: 6.529

4.  Functional consequences of cocaine re-exposure after discontinuation of cocaine availability.

Authors:  Thomas J R Beveridge; Hilary R Smith; Susan H Nader; Michael A Nader; Linda J Porrino
Journal:  Neuropharmacology       Date:  2014-06-19       Impact factor: 5.250

5.  A new Michaelis-Menten-based kinetic model for transport and phosphorylation of glucose and its analogs in skeletal muscle.

Authors:  Hsuan-Ming Huang; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

6.  Regional elevations in microglial activation and cerebral glucose utilization in frontal white matter tracts of rhesus monkeys following prolonged cocaine self-administration.

Authors:  Hilary R Smith; Thomas J R Beveridge; Susan H Nader; Michael A Nader; Linda J Porrino
Journal:  Brain Struct Funct       Date:  2019-02-12       Impact factor: 3.270

Review 7.  Brain injury: new insights into neurotransmitter and receptor mechanisms.

Authors:  H M Pappius
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

8.  Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading.

Authors:  Kenji Ishibashi; Kei Wagatsuma; Kiichi Ishiwata; Kenji Ishii
Journal:  Hum Brain Mapp       Date:  2016-04-08       Impact factor: 5.038

9.  Dynamic functional imaging of brain glucose utilization using fPET-FDG.

Authors:  Marjorie Villien; Hsiao-Ying Wey; Joseph B Mandeville; Ciprian Catana; Jonathan R Polimeni; Christin Y Sander; Nicole R Zürcher; Daniel B Chonde; Joanna S Fowler; Bruce R Rosen; Jacob M Hooker
Journal:  Neuroimage       Date:  2014-06-14       Impact factor: 6.556

10.  Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using (13)C nuclear magnetic resonance spectroscopy.

Authors:  Pierre-Gilles Henry; Amy B Criego; Anjali Kumar; Elizabeth R Seaquist
Journal:  Metabolism       Date:  2009-09-18       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.